-
AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Amedica's Si3n4 great fit for Nuvasive
Discussion in 'NuVasive' started by Boston745, Jan 7, 2018 at 11:53 AM.
Page 1 of 2
Page 1 of 2